Companies: 10,795·Total market cap: $144.5T

Sagimet Biosciences Inc.

Sagimet Biosciences Inc.

SGMTNASDAQHealthcare● Active

$6.53

$-0.23(-3.40%)

Market Cap$212759134

P/E Ratio—

52W High$11.41

52W Low$4.5

Avg Volume1.5M

Open$6.95

Beta3.44

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Sagimet Biosciences Inc.（SGMT）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · SGMT · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-1.35Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding32.3MShares outstanding history

Next EarningsAug 12, 2026Est.Earnings history

探索 Sagimet Biosciences Inc. 数据

分析师预测$8 · Buy

股息不分红

盈利EPS $-1.58-8.97%

财务快照

FY 2025Revenue$0.00

202320242025

FY 2025Net Income-$51.0M▼ 12.01% YoY

202320242025

FY 2025EPS$-1.58▼ 8.97% YoY

202320242025

TTM:Revenue: $0.00Net Income: -$43.5MEPS: $-1.35View income statement →

分析师评级与目标价

Buy7 位分析师

Strong Buy

0

Buy

6

Hold

1

Sell

0

Strong Sell

0

12-Month Price Target

$8.00Low

$6.53Current

$8.00Avg Target上涨空间 22.51%

$8.00High

合计: 7 · 买入占比: 85.7%

根据过去 3 个月内 7 位华尔街分析师，SGMT 共识评级为 Buy，12 个月平均目标价 $8.00 （较现价 $6.53 上涨空间 22.51%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Sagimet Biosciences Inc.

$6.53-3.40%$212.8M #2

Achieve Life Sciences, Inc.

$5.48+6.82%$562.6M #3

Arcturus Therapeutics Holdings Inc.

$7.12-2.47%$202.4M #4

Assembly Biosciences, Inc.

$22.56-1.51%$358.5M #5

Atea Pharmaceuticals, Inc.

$4.32+1.65%$345.7M #6

Foghorn Therapeutics Inc.

$3.71-0.54%$217.8M

股票表现

1D-3.40%

1W-4.81%

1M-15.30%

3M+21.38%

YTD+10.30%

1Y+22.51%

5Y-59.06%

关于 Sagimet Biosciences Inc.

CEODavid A. Happel

IPO DateJul 17, 2023

Employees14

CountryUS

Websitesagimet.com

Sagimet Biosciences Inc. is a biopharmaceutical company with drug candidates in clinical trials, specializing in developing therapies that target fatty acid synthase (FASN) inhibition. These treatment…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

Sagimet Biosciences Inc.（SGMT）是 Biotechnology 行业的 Healthcare 类公司，于 Jul 17, 2023 在 NASDAQ 上市。截至最近交易日，SGMT 股价为 $6.53，市值约为 $212.8M。过去12个月累计回报 +22.51%，年初至今回报 +10.30%。

根据 7 位华尔街分析师，Sagimet Biosciences Inc. 股票共识评级为Buy，12个月平均目标价为 $8.00。2025 财年 Sagimet Biosciences Inc. 营收 —，净利润 -$51.0M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Sagimet Biosciences Inc.（SGMT）股价为 $6.53，在 NASDAQ 上市，52周区间为 $4.50 – $11.41。

SGMT 最新股价SGMT quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议